Clarivate report: nearly 70% vaccinated by September 2021

Posted 23 July 2021

Clarivate Forecasts Nearly 70% of North American, European and Asia Pacific Adult Populations Will Be Vaccinated for COVID-19 by September 2021

New report analyses how the emergence and increased availability of vaccines will impact the recovery of healthcare markets across the globe

Clarivate Plc, a global leader in providing trusted information and insights to accelerate the pace of innovation, announced the launch of its COVID-19 Vaccine Availability and Medtech Impact Report which features retrospective, current and predictive analysis to forecast an estimate of the rate at which vaccination will occur in each country in 2021. The report found that, despite continued public health measures in 2021, it is expected that the emergence of multiple vaccines in late 2020 and the rollout of these vaccines globally will determine how healthcare markets recover in 2021 and beyond.

Lockdowns, procedure deferrals, clinical trial pauses and M&A challenges all impact the fundamental operations of healthcare stakeholders. Real world data from Clarivate provides a clear understanding of past trends and allows for predictive forecasting to enable more confident decision-making for stakeholders tasked with the recovery of healthcare systems.

The report details the current vaccine development status and the various distinctions between available vaccines, an analysis of global vaccination rollout campaigns, how these factors influence forecasting and the impact of vaccination availability on healthcare markets and sectors.

Zaid Al-Nassir, Principal Analyst, Medtech Insights, Clarivate, said: “Given the lack of historical data and immense pressure on health care stakeholders globally, predictive analysis of recovery drivers, such as vaccination, provides a unique insight for planning, decision making, and both market and regional targeting. The new imperative for global health, driven by the COVID-19 pandemic, has amplified the need for connected data to support complex analyses and evidence-based decisions in the life sciences.”

Download the full report now: COVID-19 Vaccine Availability and Medtech Impact Report

Methodology for the Clarivate COVID-19 report

Forecasts and insights provided in this report were developed by Clarivate analysts, using a diversity of proprietary sources, including: Market Tracking: Medical Supply Distribution data enables manufacturers to identify opportunities and risks by confidently assessing market share based on real-time insights; Clarivate Real World Data™ product, which provides access to real-word data, such as patient volumes by procedure group and site of service; Medtech Insights™, which provides comprehensive data forecasts and analysis for global and regional medical device markets; and Market Assessment Epidemiology™, which provides solutions to understand the complete disease landscape and size global markets with real-world data.

About Clarivate

Clarivate™ is a global leader in providing solutions to accelerate the lifecycle of innovation. Our bold mission is to help customers solve some of the world’s most complex problems by providing actionable information and insights that reduce the time from new ideas to life-changing inventions in the areas of science and intellectual property. We help customers discover, protect and commercialise their inventions using our trusted subscription and technology-based solutions coupled with deep domain expertise. For more information, please visit clarivate.com.

Home

News & opinion

Member Directory

Events